EUS 3.0-Tesla MRCP trial

Endoscopic ultrasound versus 3.0-Tesla magnetic resonance cholangiopancreatography for the diagnosis of computed tomography-negative common bile duct stone: randomized controlled trial

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT1032220442

Enrollment

Registered

2022-11-07

Start date

2022-11-22

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

choledocholithiasis

Interventions

MRCP group:undergo 3.0-Tesla MRCP EUS group:undergo EUS

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)20 years of age or older. 2)Met the diagnostic criteria for suspected or definite acute cholangitis of mild or moderate severity according to TG18 despite negative CT results for choledocholithiasis. 3)Provided written informed consent.

Exclusion criteria

Exclusion criteria: 1)Patients with claustrophobia. 2)Patients with non-MRI compatible metal implants. 3)Patients who have an altered or postsurgical upper gastrointestinal anatomy. 4)Pregnant or lactating women. 5)Patients with severe acute cholangitis as per the TG18 guideline. 6)Patients otherwise deemed unfit by the investigators based on their clinical judgment.

Design outcomes

Primary

Measure	Time frame
diagnostic accuracy	—

Secondary

Measure	Time frame
sensitivity,specificity, positive predictive value, and negative predictive value detection rate of choledocholithiasis in the second examination sensitivity,specificity, positive predictive value, and negative predictive value in the whole exmination adverse events	—

Contacts

Public ContactMasato Suzuki

National Hospital Organization Yokohama Medical Center

d07sm056@gmail.com+81-45-851-2621

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026